These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 189576

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. Streptozotocin-induced diabetic ketoacidosis in a patient with metastatic islet-cell carcinoma.
    Berends M, Lesterhuis WJ, van Laarhoven HW.
    Neth J Med; 2013 Dec; 71(10):541-2. PubMed ID: 24394744
    [Abstract] [Full Text] [Related]

  • 65. Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor.
    Del Prato S, Rovira A, Tessari P, Avogaro A, Nosadini R, Valverde I, Trevisan R, Tiengo A.
    J Endocrinol Invest; 1984 Apr; 7(2):111-5. PubMed ID: 6327796
    [Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Phase II study of chlorozotocin in islet cell carcinoma. A southwest Oncology Group study.
    Bukowski RM, McCracken JD, Balcerzak SP, Fabian CJ.
    Cancer Chemother Pharmacol; 1983 Apr; 11(1):48-50. PubMed ID: 6309425
    [Abstract] [Full Text] [Related]

  • 69. Streptozotocin for metastatic insulinoma.
    JAMA; 1970 Nov 02; 214(5):907. PubMed ID: 4319193
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. A malignant insulinoma transformed into a glucagonoma syndrome.
    Ohneda A, Otsuki M, Fujiya H, Yaginuma N, Kokubo T, Ohtani H.
    Diabetes; 1979 Nov 02; 28(11):962-9. PubMed ID: 226443
    [No Abstract] [Full Text] [Related]

  • 73. Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin.
    Murray-Lyon IM, Eddleston AL, Williams R, Brown M, Hogbin BM, Bennett A, Edwards JC, Taylor KW.
    Lancet; 1968 Oct 26; 2(7574):895-8. PubMed ID: 4176152
    [No Abstract] [Full Text] [Related]

  • 74. Forced diuresis to reduce nephrotoxicity of streptozotocin in the treatment of advanced metastatic insulinoma.
    Tobin MV, Warenius HM, Morris AI.
    Br Med J (Clin Res Ed); 1987 May 02; 294(6580):1128. PubMed ID: 3034373
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Notes on streptozotocin in metastatic insulinoma.
    Vogel TT.
    J Surg Oncol; 1971 May 02; 3(5):481-5. PubMed ID: 4329781
    [No Abstract] [Full Text] [Related]

  • 78. Treatment of malignant insulinoma with Streptozotocin.
    Smith CK, Stoll RW, Vance J, Ricketts H, Williams RH.
    Diabetologia; 1971 Apr 02; 7(2):118-24. PubMed ID: 4325749
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.